281 related articles for article (PubMed ID: 15894612)
1. The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure.
Garrity D; Call ME; Feng J; Wucherpfennig KW
Proc Natl Acad Sci U S A; 2005 May; 102(21):7641-6. PubMed ID: 15894612
[TBL] [Abstract][Full Text] [Related]
2. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.
Upshaw JL; Arneson LN; Schoon RA; Dick CJ; Billadeau DD; Leibson PJ
Nat Immunol; 2006 May; 7(5):524-32. PubMed ID: 16582911
[TBL] [Abstract][Full Text] [Related]
3. An activating immunoreceptor complex formed by NKG2D and DAP10.
Wu J; Song Y; Bakker AB; Bauer S; Spies T; Lanier LL; Phillips JH
Science; 1999 Jul; 285(5428):730-2. PubMed ID: 10426994
[TBL] [Abstract][Full Text] [Related]
4. Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12.
Fikri Y; Nyabenda J; Content J; Huygen K
Immunogenetics; 2007 Aug; 59(8):653-9. PubMed ID: 17530242
[TBL] [Abstract][Full Text] [Related]
5. The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation.
Roda-Navarro P; Reyburn HT
J Biol Chem; 2009 Jun; 284(24):16463-16472. PubMed ID: 19329438
[TBL] [Abstract][Full Text] [Related]
6. NKG2D splice variants: a reexamination of adaptor molecule associations.
Rabinovich B; Li J; Wolfson M; Lawrence W; Beers C; Chalupny J; Hurren R; Greenfield B; Miller R; Cosman D
Immunogenetics; 2006 Apr; 58(2-3):81-8. PubMed ID: 16470377
[TBL] [Abstract][Full Text] [Related]
7. The assembly of diverse immune receptors is focused on a polar membrane-embedded interaction site.
Feng J; Call ME; Wucherpfennig KW
PLoS Biol; 2006 May; 4(5):e142. PubMed ID: 16623599
[TBL] [Abstract][Full Text] [Related]
8. Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1.
Park YP; Choi SC; Kiesler P; Gil-Krzewska A; Borrego F; Weck J; Krzewski K; Coligan JE
Blood; 2011 Sep; 118(11):3019-27. PubMed ID: 21816829
[TBL] [Abstract][Full Text] [Related]
9. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells.
Quatrini L; Molfetta R; Zitti B; Peruzzi G; Fionda C; Capuano C; Galandrini R; Cippitelli M; Santoni A; Paolini R
Sci Signal; 2015 Oct; 8(400):ra108. PubMed ID: 26508790
[TBL] [Abstract][Full Text] [Related]
11. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway.
Horng T; Bezbradica JS; Medzhitov R
Nat Immunol; 2007 Dec; 8(12):1345-52. PubMed ID: 17952078
[TBL] [Abstract][Full Text] [Related]
12. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
13. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
[TBL] [Abstract][Full Text] [Related]
14. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells.
Wu J; Cherwinski H; Spies T; Phillips JH; Lanier LL
J Exp Med; 2000 Oct; 192(7):1059-68. PubMed ID: 11015446
[TBL] [Abstract][Full Text] [Related]
15. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway.
Billadeau DD; Upshaw JL; Schoon RA; Dick CJ; Leibson PJ
Nat Immunol; 2003 Jun; 4(6):557-64. PubMed ID: 12740575
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
[TBL] [Abstract][Full Text] [Related]
17. UL16 binding proteins.
Cao W; He W
Immunobiology; 2004; 209(3):283-90. PubMed ID: 15518340
[TBL] [Abstract][Full Text] [Related]
18. A Structural basis for the association of DAP12 with mouse, but not human, NKG2D.
Rosen DB; Araki M; Hamerman JA; Chen T; Yamamura T; Lanier LL
J Immunol; 2004 Aug; 173(4):2470-8. PubMed ID: 15294961
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of pig immunoreceptor DAP10 and NKG2D.
Yim D; Jie HB; Sotiriadis J; Kim YS; Kim KS; Rothschild MF; Lanier LL; Kim YB
Immunogenetics; 2001 Apr; 53(3):243-9. PubMed ID: 11398969
[TBL] [Abstract][Full Text] [Related]
20. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
